Microcrystalline cellulose

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

5346 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	179	300	56	5	27	487
Type 2 diabetes mellitus	D003924	EFO_0001360	E11	51	47	131	90	62	376
Lymphoma	D008223	—	C85.9	123	228	35	5	29	359
Diabetes mellitus	D003920	HP_0000819	E08-E13	26	54	131	79	36	317
Syndrome	D013577	—	—	67	137	34	28	55	288
Myelodysplastic syndromes	D009190	—	D46	76	145	17	1	16	224
Myeloid leukemia	D007951	—	C92	82	120	19	1	8	198
Healthy volunteers/patients	—	—	—	125	13	8	11	48	197
Myeloid leukemia acute	D015470	—	C92.0	84	113	21	1	8	195
Lymphoid leukemia	D007945	—	C91	63	117	33	3	8	192

Show 612 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Plasma cell neoplasms	D054219	—	—	36	62	2	—	13	102
Hodgkin disease	D006689	—	C81	24	63	11	—	7	90
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	19	65	4	—	4	83
Lung neoplasms	D008175	HP_0100526	C34.90	17	34	20	—	2	67
Hematologic neoplasms	D019337	—	—	30	40	3	—	4	66
Myelodysplastic-myeloproliferative diseases	D054437	—	—	15	42	5	—	7	63
Follicular lymphoma	D008224	—	C82	24	40	4	—	7	62
Mantle-cell lymphoma	D020522	—	—	27	38	3	—	6	61
Graft vs host disease	D006086	—	D89.81	11	41	9	—	3	57
Small cell lung carcinoma	D055752	—	—	15	28	15	—	1	54

Show 371 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Plasmacytoma	D010954	—	C90.3	16	32	—	—	9	53
B-cell lymphoma marginal zone	D018442	—	C88.4	13	25	—	—	7	39
T-cell lymphoma cutaneous	D016410	—	—	8	16	—	—	7	28
Mycosis fungoides	D009182	—	C84.0	9	16	—	—	6	27
Lymphomatoid granulomatosis	D008230	—	C83.8	8	17	—	—	6	27
T-cell leukemia	D015458	—	—	7	17	—	—	5	26
Myeloid leukemia accelerated phase	D015465	—	—	5	20	—	—	3	26
Sezary syndrome	D012751	—	C84.1	7	15	—	—	6	25
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	5	14	—	—	5	22
Blast crisis	D001752	—	—	5	15	—	—	1	19

Show 346 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Tissue adhesions	D000267	—	—	1	—	—	—	6	7
Dengue	D003715	—	A90	6	—	—	—	—	6
Pruritus	D011537	HP_0000989	L29	2	—	—	—	3	5
Autism spectrum disorder	D000067877	HP_0000729	F84.0	2	—	—	—	3	5
Healthy aging	D000073656	—	—	1	—	—	—	3	4
Impacted tooth	D014095	HP_0011079	K01.1	1	—	—	—	3	4
Hidradenitis suppurativa	D017497	—	L73.2	1	—	—	—	2	3
Hidradenitis	D016575	—	—	1	—	—	—	2	3
Drug interactions	D004347	—	—	2	—	—	—	1	3
Papillomavirus infections	D030361	—	—	1	—	—	—	1	2

Show 105 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Peri-implantitis	D057873	EFO_1001390	—	—	—	—	—	5	5
Sinus floor augmentation	D059546	—	—	—	—	—	—	5	5
Psychological well-being	D000092862	—	—	—	—	—	—	5	5
Affect	D000339	—	—	—	—	—	—	4	4
Psychological stress	D013315	—	—	—	—	—	—	4	4
Healthy diet	D000072001	—	—	—	—	—	—	4	4
Graves disease	D006111	EFO_0004237	E05.0	—	—	—	—	3	3
Sedentary behavior	D057185	—	—	—	—	—	—	3	3
Acid-base imbalance	D000137	—	—	—	—	—	—	3	3
Flatfoot	D005413	EFO_0003874	—	—	—	—	—	3	3